| Fund Name | Location |
| Actua Corporation | Pennsylvania, Radnor, United States |
| Aetius Capital | Central, Central Region, Singapore |
| AirSpeed18 | China, Hong Kong, Hong Kong Island |
| Bray Capital | England, London, United Kingdom |
| Guangdong Lihe Kaiwu Venture Capital Fund | China, Guangdong Province, Huizhou |
| Handnice Capital | China, Hangzhou, Zhejiang |
| Happy Farm Business Accelerator | - |
| HSBC Bank | Illinois, Lake Forest, United States |
| Huafu Securities Co., Ltd. | China, Foochow, Fujian |
| InnoSuisse | Bern, Berne, Switzerland |
| Motive Partners | New York, New York, United States |
| Nascent Ventures | England, London, United Kingdom |
| Ombu Group | England, London, United Kingdom |
| OSK Ventures International | Kuala Lumpur, Malaysia |
| Pari Capital Group | Bayern, Germany, Munich |
| Rutledge Vine Capital | Central, Central Region, Singapore |
| Seen & Speed Ventures | - |
| Technion | Hefa, Hefa, Israel |
| Vision Capital | England, London, United Kingdom |
| Yingli Huifeng | China, Guangdong, Tianjin |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Ocuphire Pharma | $5M | 22 Jul 2019 | Michigan, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Ocuphire Pharma | $5M | 22 Jul 2019 | Michigan, United States |
